Concepedia

Author

S. Nagel

Martha-Maria Hospital

Also Known As

S Nagel, S. Nagel, S.N. Nagel, STEVEN NAGEL, Sylke Nagel

60

Publications

527

Citations

11

H-Index

34

Concepts

All Affiliations

Martha-Maria HospitalUniversity Hospital HeidelbergHeidelberg UniversityUniversity Hospital UlmKlinikum St. Marien Amberg
SN

About

S. Nagel is an author at Martha-Maria Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

215

2

Health Sciences

3

3

143

3

Engineering

1

1

16

4

Cell Biology

1

1

111

5

Immunology

1

1

111

S. Nagel

×

9

Publications

413

Citations

9

H-Index

YearCitations

Phase III Study of Second-Line Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Weekly Compared With 3-Weekly Docetaxel

Wolfgang Schuette, S. Nagel, Thomas Blankenburg,

Journal of Clinical Oncology

2005

181

Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK)

Christoph Rochlitz, Andreas Lohri, M. Bacchi,

Leukemia

1999

111

Phase II Trial of Gemcitabine/Irinotecan in Refractory or Relapsed Small-Cell Lung Cancer

Wolfgang Schuette, S. Nagel, Stefan Juergens,

Clinical Lung Cancer

2005

28

Clinical Benefit in NSCLC: Advanced-Stage Patients Require Symptom-Improving Palliation. Experiences from the ‘Iressa’ Expanded Access Program

Wolfgang Schuette, S. Nagel, Steffen Schaedlich,

Oncology Research and Treatment

2005

17

Second-line chemotherapy for advanced non-small cell lung cancer (NSCLC) with weekly versus three-weekly docetaxel: Results of a randomized phase III study

Wolfgang Schuette, S. Nagel, Monika Serke,

Journal of Clinical Oncology

2004

17

Quantitative diffusion tensor imaging in herpes simplex virus encephalitis

Christian Herweh, M.R. Jayachandra, M. Hartmann,

Journal of NeuroVirology

2007

16

Randomized Phase III Trial of Docetaxel Plus Carboplatin with or without Levofloxacin Prophylaxis in Elderly Patients with Advanced Non-small Cell Lung Cancer: The APRONTA Trial

Wolfgang Schuette, S. Nagel, Ludwig Fischer von Weikersthal,

Journal of Thoracic Oncology

2011

15

Addition of Darbepoetin Alfa to Dose-Dense Chemotherapy: Results From a Randomized Phase II Trial in Small-Cell Lung Cancer Patients Receiving Carboplatin Plus Etoposide

S. Nagel, O Kellner, Walburga Engel-Riedel,

Clinical Lung Cancer

2011

14

Vasogenic Brain Edema During Maintenance Hemodialysis

M. Schaier, Robert Christian Wolf, Katharina M. Kubera,

Clinical Neuroradiology

2019

14

Page 1